Astellas Pharma Inc.
A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.
4503 | T
Overview
Corporate Details
- ISIN(s):
- JP3942400007
- LEI:
- Country:
- Japan
- Address:
- 中央区日本橋本町二丁目５番１号
- Website:
- https://www.astellas.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Astellas Pharma Inc. is a global pharmaceutical company dedicated to improving human health by turning innovative science into value for patients. Formed in 2005 from the merger of Yamanouchi Pharmaceutical Co. and Fujisawa Pharmaceutical Co., the company engages in the research, development, manufacturing, and marketing of innovative pharmaceutical products. Astellas focuses on addressing unmet medical needs in several therapeutic areas, with a primary emphasis on oncology. Its key areas of innovation also include gene therapy, immuno-oncology, regenerative medicine, and treatments for blindness and mitochondrial diseases. The company is committed to a stable supply of reliable medicines worldwide and stands at the forefront of healthcare change.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-06 03:29 |
Report Publication Announcement
確認書
|
Japanese | 8.9 KB | ||
| 2025-11-06 03:26 |
Interim Report
半期報告書－第21期(2025/04/01－2026/03/31)
|
Japanese | 310.0 KB | ||
| 2025-07-31 08:30 |
Registration Form
訂正発行登録書
|
Japanese | 9.7 KB | ||
| 2025-07-31 04:04 |
Post-Annual General Meeting Information
訂正臨時報告書
|
Japanese | 33.0 KB | ||
| 2025-07-03 08:31 |
Registration Form
訂正発行登録書
|
Japanese | 10.3 KB | ||
| 2025-07-02 02:28 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 24.1 KB | ||
| 2025-06-16 06:14 |
Governance Information
内部統制報告書－第20期(2024/04/01－2025/03/31)
|
Japanese | 23.1 KB | ||
| 2025-06-16 06:11 |
Registration Form
確認書
|
Japanese | 8.7 KB | ||
| 2025-06-16 06:09 |
Annual Report
有価証券報告書－第20期(2024/04/01－2025/03/31)
|
Japanese | 2.5 MB | ||
| 2025-02-04 07:47 |
Registration Form
訂正発行登録書
|
Japanese | 9.9 KB | ||
| 2025-02-04 07:40 |
Regulatory News Service
臨時報告書
|
Japanese | 19.4 KB | ||
| 2025-02-04 07:39 |
Regulatory News Service
臨時報告書
|
Japanese | 20.9 KB | ||
| 2024-11-06 05:52 |
Interim Report
確認書
|
Japanese | 8.9 KB | ||
| 2024-11-06 05:51 |
Interim Report
半期報告書－第20期(2024/04/01－2025/03/31)
|
Japanese | 344.2 KB | ||
| 2024-09-03 03:34 |
Registration Form
発行登録追補書類（株券､社債券等）
|
Japanese | 96.0 KB |
Automate Your Workflow. Get a real-time feed of all Astellas Pharma Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Astellas Pharma Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Astellas Pharma Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
